C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2001
10/25/2001	WO2001079481A2 Methods of constructing display libraries of genetic packages for members of a diverse family of peptides
10/25/2001	WO2001079480A1 Albumin fusion proteins
10/25/2001	WO2001079468A2 Drug metabolizing enzymes
10/25/2001	WO2001079455A1 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN
10/25/2001	WO2001079448A2 Trp8, a transient receptor potential channel expressed in taste receptor cells
10/25/2001	WO2001079444A2 Albumin fusion proteins
10/25/2001	WO2001079443A2 Albumin fusion proteins
10/25/2001	WO2001079442A2 Albumin fusion proteins
10/25/2001	WO2001079300A1 Surface-bound antigen binding portions of antibodies that bind to ctla-4 and cd28 and uses therefor
10/25/2001	WO2001079299A1 Enhancement of antibody-mediated immune responses
10/25/2001	WO2001079298A1 Novel recombinant antibodies, amino acid sequences of cdrs thereof and genes encoding the same
10/25/2001	WO2001079296A1 Humar emr2, a g-protein coupled receptor from the egf-tm7 family
10/25/2001	WO2001079291A2 Secreted proteins
10/25/2001	WO2001079288A2 Cytokine uses; compositions; methods
10/25/2001	WO2001079286A2 Compositions and methods for the therapy and diagnosis of breast cancer
10/25/2001	WO2001079282A2 Molecules associated with human reproduction
10/25/2001	WO2001079271A1 Albumin fusion proteins
10/25/2001	WO2001079269A2 Lipid binding protein 4
10/25/2001	WO2001079266A1 Antibody against human kgfr
10/25/2001	WO2001079265A1 Antibody against human kgf
10/25/2001	WO2001079258A1 Albumin fusion proteins
10/25/2001	WO2001079253A1 Extracellular matrix polynucleotides, polypeptides, and antibodies
10/25/2001	WO2001078796A1 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor
10/25/2001	WO2001078779A2 Antibody alpha4beta7 integrin and its use to treat inflammatory bowel disease
10/25/2001	WO2001078778A1 USE OF INHIBITION OF A Gas6 FUNCTION OR OF A Gas6 RECEPTOR FOR PREVENTING AND TREATING A CARDIOVASCULAR DISEASE
10/25/2001	WO2001078768A2 Targeted vaccine delivery systems
10/25/2001	WO2001078766A1 Vaccine against cancerous diseases which is based on mimotopes of antigens expressed on tumor cells
10/25/2001	WO2001078755A2 A novel polypeptide - human ataxia-telangiectasia mutant protein 9 and a polynucleotide encoding the same
10/25/2001	WO2001078708A1 Treating graft rejection with cxcr3 inhibitors
10/25/2001	WO2001078707A1 Treating graft rejection with ccr5 inhibitors
10/25/2001	WO2001078698A2 Use of ngf-antagonists for the prevention or treatment of chronic visceral pain
10/25/2001	WO2001078653A2 Graft rejection inhibition with ccr2 inhibitors
10/25/2001	WO2001039786A3 New uses of suppressive macrophage activation factors
10/25/2001	WO2001027159A3 Polypeptides for detection and elimination of ca19-9 antigen positive cells
10/25/2001	WO2001026679A3 T-cells and molecules involved in immune regulation
10/25/2001	WO2001023570A3 Methods and compositions relating to sodium channel beta-1a subunits
10/25/2001	WO2001012790A3 Isomerase proteins
10/25/2001	WO2001012663A3 Hematopoietic regulatory factors and methods of use thereof
10/25/2001	WO2001000245A3 HUMANIZED ANTI-ErbB2 ANTIBODIES AND TREATMENT WITH ANTI-ErbB2 ANTIBODIES
10/25/2001	WO2000047618A9 HUMAN β-SECRETASE ENZYME, INHIBITORS AND THEIR COMPOSITIONS AND USES
10/25/2001	WO2000047104A3 Antagonists of hmg1 for treating inflammatory conditions
10/25/2001	WO2000045178A9 Method of evaluating myelosuppressive state
10/25/2001	WO2000011169A3 Human cell signaling proteins (csig)
10/25/2001	US20010034436 Polynucleotide and polypeptides, screening for antibiotic activity, Staphylococcus
10/25/2001	US20010034334 Genetic engineered polypeptide
10/25/2001	US20010034327 Suppression of inhibitors
10/25/2001	US20010034062 For engineering cells for delivery of antibodies to combat respiratory diseases, viral infection, asthma, allergy, and macular degeneration
10/25/2001	US20010034052 A breast tumor polypeptide(s), immunogenic portions thereof, polynucleotides that encode such peptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides; vaccines
10/25/2001	US20010034024 Mutations in and genomic structure of HERG - a long QT syndrome gene
10/25/2001	US20010034021 Antibodies that specifically react with seroreactive regions on HPV 16 proteins E1 and E2
10/25/2001	US20010034018 Contacting a sample with an antibody which binds to SVI (Sentinel virus 1) or a protein and the antibody does not bind TTV strains SANBAN and TUS01 or protiens and detecting the complexes of antibody and SVI virus or protein
10/25/2001	US20010033842 Immunoglobulin antagonist
10/25/2001	US20010033841 Atherosclerosis therapy
10/25/2001	US20010033840 Methods for inducing T cell tolerance to a tissue or organ graft
10/25/2001	US20010033839 Vaccine kits
10/25/2001	DE10019967A1 New recombinant antibody specific for native gp96, useful for isolating gp96 as complex with endogenous peptides, used for autologous immunotherapy of e.g. tumor
10/25/2001	DE10018963A1 Determination of iodinated thyroglobulin, useful for detecting residual thyroid cancer or metastases after surgery, comprises immunoassay after administration of 131-iodine
10/25/2001	CA2798625A1 Novel methods of constructing libraries of genetic packages that collectively display the members of a diverse family of peptides, polypeptides or proteins
10/25/2001	CA2747325A1 Albumin fusion proteins
10/25/2001	CA2406481A1 Trp8, a transient receptor potential channel expressed in taste receptor cells
10/25/2001	CA2406378A1 Targeted vaccine delivery systems
10/25/2001	CA2406245A1 Il-174 uses, compositions and methods
10/25/2001	CA2406220A1 Antibody alpha4beta7 integrin and its use to treat inflammatory bowel disease
10/25/2001	CA2406213A1 Compositions and methods for the therapy and diagnosis of breast cancer
10/25/2001	CA2406195A1 Lipid binding protein 4
10/25/2001	CA2406126A1 Humar emr2, a g-protein coupled receptor from the egf-tm7 family
10/25/2001	CA2406087A1 New lipid binding protein 2
10/25/2001	CA2406066A1 Lipid binding protein 3
10/25/2001	CA2405781A1 Secreted proteins
10/25/2001	CA2405709A1 Albumin fusion proteins
10/25/2001	CA2405701A1 Albumin fusion proteins
10/25/2001	CA2405563A1 Albumin fusion proteins
10/25/2001	CA2405557A1 Albumin fusion proteins
10/25/2001	CA2405550A1 Albumin fusion proteins
10/25/2001	CA2405525A1 Albumin fusion proteins
10/25/2001	CA2405451A1 Molecules associated with human reproduction
10/25/2001	CA2404127A1 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor
10/25/2001	CA2404117A1 Use of ngf-antagonists for the prevention or treatment of chronic visceral pain
10/25/2001	CA2403644A1 Drug metabolizing enzymes
10/25/2001	CA2403547A1 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
10/25/2001	CA2403508A1 Extracellular matrix polynucleotides, polypeptides, and antibodies
10/25/2001	CA2399940A1 Enhancement of antibody-mediated immune responses
10/25/2001	CA2376882A1 Novel recombinant antibody, amino acid sequences of its complementarity determining regions and genes encoding the same
10/25/2001	CA2370572A1 Kv10.1, a novel voltage-gated potassium channel from human brain
10/24/2001	EP1148339A2 Immunoassay for LSD and 2-Oxo-3-Hydroxy-LSD
10/24/2001	EP1148125A1 Human nucleoprotein having www domain and polynucleotide encoding the same
10/24/2001	EP1147213A2 Novel rgs-containing molecules and uses thereof
10/24/2001	EP1147201A2 Metalloproteinase-disintegrin family members: svph dnas and polypeptides
10/24/2001	EP1147196A1 Polymorphic loci that differentiate escherichia coli 0157:h7 from other strains
10/24/2001	EP1147195A1 Candida albicans srb-7
10/24/2001	EP1147194A1 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
10/24/2001	EP1147193A1 Platelet-derived growth factor/vascular endothelial growth factor-like growth factor h, and uses thereof
10/24/2001	EP1147137A1 Methods for generating phosphorylation site-specific immunological reagents
10/24/2001	EP1147136A1 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF
10/24/2001	EP1147134A1 Novel potassium channels and genes encoding these potassium channels
10/24/2001	EP1147123A2 Novel odorant receptors in drosophila
10/24/2001	EP1146903A1 Glypicans for the detection and treatment of human carcinoma
10/24/2001	EP1146902A1 Treatment of autommune diseases by an agonistic cd40-binding protein
10/24/2001	EP1146898A1 Vaccine-mediated treatment of neurological disorders
10/24/2001	EP1146892A2 Baff, inhibitors thereof and their use in the modulation of the b-cell response

1 ... 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 ... 1494